Log in  First Connection?

Kidney TransplantationArchives

Safety of biologic therapy in kidney and liver transplant recipients with systemic inflammatory diseases: a real-world study from Israel

 Published on 11/02/2026 |  Original article (Full-text)  | Victoria Furer et al. | Rheumatology. Volume 64(10).

Safety is a concern for solid-organ transplant (SOT) recipients with systemic inflammatory diseases (SIDs) treated with biologic therapy. This study evaluated the safety of biologic therapy in SOT recipients with SIDs. Methods: This retrospective study between 2000 and 2024 included 20 biologic-treated...

It never rains but pours: disseminated nocardiosis in a renal transplant patient from Nigeria – a case report

 Published on 04/02/2026 |  Original article (Full-text)  | Whitehead Thomas et al. | BMC Infectious Diseases 2025; 26(1): 117

Nocardia are ubiquitous Gram-positive, acid-fast bacteria found worldwide in soil and both fresh- and saltwater. The main route of infection is inhalation [1] but primary cutaneous infection can also occur following traumatic inoculation [2]. These environmental organisms were first described by French...

Continuous glucose monitoring in kidney transplant recipients: a narrative review

 Published on 28/01/2026 |  Original article (Full-text)  | Oweidat Khaled et al. | BMC Nephrology 2025; 27(1): 63

Continuous glucose monitoring (CGM) has become a transformative technology in diabetes management. Compared with traditional monitoring methods, which rely on intermittent blood or urine sampling only offering a fragmented view of glucose dynamics, CGM continuously tracks glucose levels in the interstitial...

Remimazolam tosylate vs. propofol: effects on anesthetic efficacy and renal function in living donor kidney transplantation

 Published on 21/01/2026 |  Original article (Full-text)  | Wu Jiaxin et al. | BMC Anesthesiology 2025; 25(1): 617

Propofol is the most widely used short-acting sedative in clinical practice. It inhibits histamine release in the hypothalamus by activating central gamma-aminobutyric acid A (GABA) receptors, blocks N-methyl-D-aspartate receptors, and modulates calcium influx to inhibit postsynaptic neuronal activity...